News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Y-box-1 protein (Yb-1) and breast cancer: Prognostic factor and target for therapy
Area: Oncology
A research group at the University of British Columbia (Vancouver) led by Sandy Dunn underlined the potential of Y-box-1 (YB-1) for the prognosis and therapy of breast cancer in two recent publications.
After analyzing more than 4049 samples the team comes to the conclusion, that a strong relationship exists between the occurrence of YB-1 and the risk of cancer relapse (See reference 1).
In addition the group shows that an inhibition of the transcription/translation factor YB-1 triggers apoptosis in aggressive tumor subtypes.
Related antibodies:
Polyclonal Y-box-1 antibodiesYB-1 (N-Term) (Human) antibodies
YB-1 (NLS) (C-Term) antibodies
Monoclonal Yb-1 antibodies for immunhistochemistry
Source: (1)Re-defining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease specific survival than estrogen receptor or HER-2 across all tumor subtypes (Breast Cancer Res. 2008 Oct 16;10(5):R86), (2) Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice (Cancer Res. 2008 Nov 1;68(21):8661-6)
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

